Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD
Clinical trial NCT04058535 · COMPLETED
Trial details
- NCT number
- NCT04058535
- Sponsor
- Alteogen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-05
- Primary completion
- 2020-12-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.